Glecaprevir plus pibrentasvir for paediatric hepatitis C infection

被引：0
|
作者：
Baker, Holly
机构：
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 6卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [21] EFFECTIVENESS AND SAFETY OF GLECAPREVIR AND PIBRENTASVIR FOR HEMODIALYSIS PATIENTS WITH HEPATITIS C VIRUS INFECTION AT A SINGLE CENTER
    Hotta, Naoki
    GUT, 2020, 69 : A71 - A71
  • [22] Glecaprevir/pibrentasvir in combination with ribavirin as rescue therapy in chronic hepatitis C
    Sanchez Suarez, Maria del Mar
    Martin Roldan, Alicia
    Cantudo Cuenca, Maria Rosa
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2024, 37 (03) : 283 - 284
  • [23] Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?
    Aghemo, Alessio
    Colombo, Massimo
    GASTROENTEROLOGY, 2018, 154 (04) : 1195 - 1196
  • [24] A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection
    Tomiyasu, Hiroka
    Nakajima, Saeko
    Kaku, Yo
    Hirata, Masahiro
    Kataoka, Tatsuki
    Nomura, Takashi
    Kabashima, Kenji
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 93 - 95
  • [25] Occult retinopathy following treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret)
    Massengill, Michael T.
    Park, Jason C.
    McAnany, J. Jason
    Hyde, Robert A.
    DOCUMENTA OPHTHALMOLOGICA, 2023, 146 (02) : 191 - 197
  • [26] Occult retinopathy following treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret)
    Michael T. Massengill
    Jason C. Park
    J. Jason McAnany
    Robert A. Hyde
    Documenta Ophthalmologica, 2023, 146 : 191 - 197
  • [27] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
    Goki Suda
    Chitomi Hasebe
    Masami Abe
    Masayuki Kurosaki
    Jun Itakura
    Namiki Izumi
    Yoshihito Uchida
    Satoshi Mochida
    Hiroaki Haga
    Yoshiyuki Ueno
    Kazumichi Abe
    Atsushi Takahashi
    Hiromasa Ohira
    Yoko Tsukuda
    Ken Furuya
    Masaru Baba
    Yoshiya Yamamoto
    Tomoe Kobayashi
    Jun Inoue
    Katsumi Terasita
    Masatsugu Ohara
    Naoki Kawagishi
    Takaaki Izumi
    Masato Nakai
    Takuya Sho
    Mitsuteru Natsuizaka
    Kenichi Morikawa
    Koji Ogawa
    Naoya Sakamoto
    Journal of Gastroenterology, 2019, 54 : 641 - 649
  • [28] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
    Suda, Goki
    Hasebe, Chitomi
    Abe, Masami
    Kurosaki, Masayuki
    Itakura, Jun
    Izumi, Namiki
    Uchida, Yoshihito
    Mochida, Satoshi
    Haga, Hiroaki
    Ueno, Yoshiyuki
    Abe, Kazumichi
    Takahashi, Atsushi
    Ohira, Hiromasa
    Tsukuda, Yoko
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Inoue, Jun
    Terasita, Katsumi
    Ohara, Masatsugu
    Kawagishi, Naoki
    Izumi, Takaaki
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    Yoshida, Junichi
    Nagasaka, Atsushi
    Fuzinaga, Akira
    Kikuchi, Hideaki
    Atarashi, Tomofumi
    Furuya, Ken
    Muto, Shuichi
    Meguro, Takashi
    Saga, Akiyoshi
    Okamoto, Munenori
    Katagiri, Masaki
    Miyagishima, Takuto
    Konno, Jun
    Kumagai, Kenichi
    Onodera, Manabu
    Kobayashi, Tomoe
    Uebayashi, Minoru
    Katou, Kanji
    Kunieda, Yasuyuki
    Tateyama, Miki
    Kawakami, Atsuhiko
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (07) : 641 - 649
  • [29] Proton-pump inhibitors and glecaprevir plus pibrentasvir in HCV infection Reply
    Forns, Xavier
    Mensa, Federico J.
    LANCET INFECTIOUS DISEASES, 2017, 17 (12): : 1240 - 1240
  • [30] ACCURACY OF GLECAPREVIR/PIBRENTASVIR RECOMMENDATIONS IN HEPATITIS C VIRUS CIRRHOTICS.
    Pichard, Anais Vallet
    Ouzan, Denis
    Abergel, Armand
    Foucher, Juliette
    Bourliere, Marc
    Hourmand, Isabelle Ollivier
    Stern, Christiane
    Rosa, Isabelle
    Pol, Stanislas
    HEPATOLOGY, 2021, 74 : 584A - 584A
12345